Iodinated contrast media during imaging procedures is associated with changes in thyroid function and increased risk of developing hyperthyroidism, researchers found.
Exposure to iodinated contrast media during imaging procedures is associated with changes in thyroid function and increased risk of developing hyperthyroidism, according to a report in the January 23 issue of Archives of Internal Medicine.
Such media are a radiology mainstay, used in such procedures as CT scans and cardiac catheterization.
Connie M. Rhee, MD, and colleagues from Brigham and Women’s Hospital and Massachusetts General Hospital in Boston examined data from patients treated between January 1990 and June 2010 who did not have preexisting hyperthyroidism or hypothyroidism. Patients were matched with healthy controls, and exposure to iodinated contrast media was assessed using claims data.
A total of 178 patients with hyperthyroidism were matched with 665 healthy controls; 213 patients with hypothyroidism were matched to779 controls. The authors found that iodinated contrast media exposure was associated with incident hyperthyroidism, but no statistically significant association was found with incident hypothyroidism.
Secondary analysis indicated an association between iodinated contrast media exposure and clinical hypothyroidism as well as hyperthyroidism.
In an accompanying commentary, Elizabeth N. Pearce, MD, of Boston University School of Medicine wrote that “Rhee et al have demonstrated that a relatively large proportion of individuals who developed iodine-induced thyroid dysfunction were not known to have underlying risk factors. Therefore, patients who may be particularly unable to tolerate thyroid dysfunction, such as those with underlying unstable cardiovascular disease, are also good candidates for monitoring of thyroid function after iodine exposure.”
Study Examines CT-Based AI Detection of Incidental Abdominal Aortic Aneurysms
April 29th 2025The AI software Viz AAA offered a sensitivity of 87.5 percent in detecting abdominal aortic aneurysms on contrast-enhanced CT, according to new retrospective research presented at the American Roentgen Ray Society (ARRS) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.